Usuda Katsuo, Ishikawa Masahito, Iwai Shun, Yamagata Aika, Iijima Yoshihito, Motono Nozomu, Matoba Munetaka, Doai Mariko, Hirata Keiya, Uramoto Hidetaka. Pulmonary Nodule and Mass: Superiority of MRI of Diffusion-Weighted Imaging and T2-Weighted Imaging to FDG-PET/CT. Cancers. 2021. 13. 20. 2-18
Motono N, Ueda Y, Shimasaki M, Iwai S, Iijima Y, Usuda K, Uramoto H. Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer. Clinical Pathology. 2021. 14. 1970430
Motono Nozomu, Ishikawa Masahito, Iwai Shun, Iijima Yoshihito, Usuda Katsuo, Uramoto Hidetaka. Individualization of risk factors for postoperative complication after lung cancer surgery: a retrospective study. BMC surgery. 2021. 21. 1. 311
Usuda Katsuo, Iwai Shun, Yamagata Aika, Iijima Yoshihito, Motono Nozomu, Doai Mariko, Matoba Munetaka, Hirata Keiya, Uramoto Hidetaka. How to Discriminate Lung Cancer From Benign Pulmonary Nodules and Masses? Usefulness of Diffusion-Weighted Magnetic Resonance Imaging With Apparent Diffusion Coefficient and Inside/Wall Apparent Diffusion Coefficient Ratio. Clinical Medicine Insights. Oncology. 2021. 15. 20K09172
Usuda Katsuo, Iwai Shun, Yamagata Aika, Iijima Yoshihito, Motono Nozomu, Matoba Munetaka, Doai Mariko, Hirata Keiya, Uramoto Hidetaka. Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses. Cancers. 2021. 13. 15. 3713